Stonewall Jackson Memorial Hospital Company

Stonewall Jackson Memorial Hospital Company was paid $12.97M by Medicaid between Jan 2018 and Dec 2024, across 206 billing codes. Its largest line is 99284, emergency room visit (serious) — 18% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	51,945	$3.51M
2019	39,924	$2.50M
2020	64,643	$3.35M
2021	61,219	$1.29M
2022	35,236	$785K
2023	40,681	$854K
2024incomplete	28,679	$682K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	18%	12,831	10,875	$2.33M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	14%	17,416	15,280	$1.87M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	6.2%	2,058	1,778	$804K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	3.5%	8,342	1,983	$449K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	2.8%	7,221	5,841	$364K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	2.7%	26,317	20,236	$356K
80053	Comprehensive metabolic panel	2.6%	21,203	16,497	$332K
99282	Emergency department visit for the evaluation and management, low to moderate severity	2.5%	4,550	4,224	$321K
74176	Computed tomography, abdomen and pelvis; without contrast material	2.1%	2,613	2,333	$276K
G0378	Hospital observation service, per hour	1.7%	2,620	1,055	$222K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	1.5%	4,619	3,930	$195K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.4%	2,161	1,431	$185K

194 more codes

36415	Collection of venous blood by venipuncture	1.4%	20,684	$184K
59025	Fetal non-stress test	1.4%	2,789	$176K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	1.3%	1,928	$167K
74177	Computed tomography, abdomen and pelvis; with contrast material	1.2%	554	$162K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	1.2%	5,060	$150K
96375	Therapeutic injection; each additional sequential IV push	1.0%	3,707	$133K
84443	Thyroid stimulating hormone (TSH)	1.0%	3,928	$131K
96361	Intravenous infusion, hydration; each additional hour	<1%	3,644	$125K
71046	Radiologic examination, chest; 2 views	<1%	3,130	$123K
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	1,000	$111K
70450	Computed tomography, head or brain; without contrast material	<1%	2,529	$108K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	5,864	$107K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	2,208	$93K
71045	Radiologic examination, chest; single view	<1%	4,404	$93K
84484		<1%	6,288	$93K
83735		<1%	3,391	$92K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	1,940	$88K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	1,935	$88K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	1,172	$86K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	1,337	$81K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	2,441	$80K
81001		<1%	7,182	$78K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	9,917	$77K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	1,617	$73K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	3,776	$69K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	1,488	$66K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	1,899	$66K
81025		<1%	2,155	$65K
76819	Fetal biophysical profile; without non-stress testing	<1%	964	$65K
83690		<1%	3,188	$59K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	970	$58K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	1,015	$54K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	4,406	$51K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	2,642	$51K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	158	$50K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	93	$48K
82150		<1%	2,622	$47K
80048	Basic metabolic panel (calcium, ionized)	<1%	2,968	$47K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	240	$47K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	667	$46K
82550		<1%	4,697	$45K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	1,408	$42K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	2,412	$40K
87070		<1%	1,636	$39K
J2704	Injection, propofol, 10 mg	<1%	2,423	$39K
81003		<1%	3,617	$39K
97164		<1%	629	$37K
83880		<1%	1,503	$37K
87086	Culture, bacterial; quantitative colony count, urine	<1%	2,542	$36K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	1,002	$34K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	101	$33K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	881	$33K
85610		<1%	2,960	$33K
93017		<1%	207	$33K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	1,341	$32K
80305		<1%	1,584	$31K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	159	$31K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	1,195	$31K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	4,743	$31K
80061	Lipid panel	<1%	2,055	$30K
93225		<1%	543	$29K
97014		<1%	1,300	$29K
71250		<1%	345	$27K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	707	$27K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	26	$27K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	275	$27K
85730		<1%	1,586	$26K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	872	$26K
93976		<1%	214	$25K
87040		<1%	1,235	$24K
82553		<1%	1,209	$24K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	230	$23K
J2785	Injection, regadenoson, 0.1 mg	<1%	113	$23K
87077		<1%	1,127	$22K
82948		<1%	2,311	$22K
87186		<1%	1,035	$22K
83605		<1%	1,284	$21K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	184	$21K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	983	$20K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	1,071	$20K
83036	Hemoglobin; glycosylated (A1C)	<1%	1,970	$19K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	118	$18K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	577	$18K
73562		<1%	433	$16K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	499	$15K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	290	$15K
73610		<1%	226	$15K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	288	$13K
84702		<1%	388	$11K
85379		<1%	528	$11K
82607		<1%	712	$11K
73030		<1%	304	$11K
86850		<1%	666	$10K
85027		<1%	855	$10K
86803		<1%	497	$10K
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	368	$10K
87634		<1%	168	$10K
73130		<1%	117	$10K
74018		<1%	238	$10K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	384	$10K
86900		<1%	822	$9K
96376		<1%	228	$9K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	1,748	$9K
84439		<1%	319	$9K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	339	$8K
97161		<1%	158	$7K
73630		<1%	178	$7K
J7030	Infusion, normal saline solution , 1000 cc	<1%	2,861	$6K
83655		<1%	389	$6K
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	192	$6K
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	193	$6K
96523		<1%	186	$6K
74019		<1%	130	$5K
72125	Computed tomography, cervical spine; without contrast material	<1%	95	$5K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	15	$5K
87481		<1%	59	$5K
87581		<1%	65	$5K
87205		<1%	328	$5K
87486		<1%	64	$5K
87420		<1%	150	$5K
74022		<1%	39	$5K
82728		<1%	344	$5K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	59	$5K
72100		<1%	92	$5K
76830	Ultrasound, transvaginal	<1%	85	$4K
86592		<1%	438	$4K
J0690	Injection, cefazolin sodium, 500 mg	<1%	105	$4K
82746		<1%	292	$4K
86901		<1%	671	$4K
87340		<1%	248	$4K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	32	$4K
A4212	Non-coring needle or stylet with or without catheter	<1%	295	$4K
97162		<1%	81	$4K
86762		<1%	178	$4K
93970		<1%	25	$3K
73502		<1%	99	$3K
83540		<1%	359	$3K
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	249	$3K
12001		<1%	26	$3K
82803		<1%	118	$3K
82565		<1%	144	$3K
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	<1%	530	$2K
86140		<1%	304	$2K
85651		<1%	66	$2K
87075		<1%	92	$2K
88304		<1%	48	$2K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	41	$2K
11721		<1%	213	$2K
J2360	Injection, orphenadrine citrate, up to 60 mg	<1%	46	$2K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	15	$2K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	108	$1K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	90	$1K
84520		<1%	106	$961.24
84703		<1%	57	$813.34
36591		<1%	96	$773.56
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	36	$717.28
94799		<1%	34	$710.48
84145		<1%	171	$668.12
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	17	$590.27
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	16	$590.27
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	15	$581.77
82950		<1%	97	$528.02
73110		<1%	30	$481.50
G0008	Administration of influenza virus vaccine	<1%	141	$449.41
73560		<1%	12	$437.23
J1815	Injection, insulin, per 5 units	<1%	47	$435.84
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	24	$419.89
A6530	Gradient compression stocking, below knee, 18-30 mmhg, each	<1%	97	$412.82
80074		<1%	13	$390.85
82043		<1%	85	$379.66
90715		<1%	26	$306.47
J1170	Injection, hydromorphone, up to 4 mg	<1%	44	$300.99
J2550	Injection, promethazine hcl, up to 50 mg	<1%	26	$258.56
99214	Doctor's office visit, returning patient (more involved)	<1%	118	$253.77
94010		<1%	318	$238.96
G8427	Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications	<1%	247	$217.73
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	2,828	$191.81
84153		<1%	12	$155.98
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	16	$154.32
73620		<1%	13	$103.39
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	<1%	12	$85.12
36600		<1%	13	$84.33
85045		<1%	25	$73.05
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	32	$53.90
J7614	Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg	<1%	26	$25.92
A4223	Infusion supplies not used with external infusion pump, per cassette or bag (list drugs separately)	<1%	21	$24.21
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	18	$10.60
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	12	$6.72
99213	Doctor's office visit, returning patient (routine)	0%	25	$0.00
G8419	Bmi documented outside normal parameters, no follow-up plan documented, no reason given	0%	41	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	14	$0.00
90662		0%	32	$0.00
J0171	Injection, adrenalin, epinephrine, 0.1 mg	0%	16	$0.00
90653		0%	25	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSCHERICH, C (VP OF FINANCE)